Vimedimex Medi-Pharma JSC
HHOSE:VMD15,300.00
VND
-50.00
(-0.33%)
ISIN
VN000000VMD9
Return %
Stock
S&P 500
1Y
-6.13
14.20
3Y
-28.84
81.12
5Y
-59.95
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Linh My Tran
- Full Time Employees
- 31
- Sector
- Health technology
- Industry
- Pharmaceuticals: generic
- Address
- Ha Noi Vietnam
- IPO Date
- Sep 30, 2010
- Similar Companies
- Business
- Vimedimex Medi-Pharma Joint Stock Company is a Vietnam-based healthcare enterprise primarily engaged in the import, export, manufacturing, distribution, and wholesale of pharmaceuticals, medical equipment, and healthcare products. The company offers a comprehensive portfolio categorized into distinct business segments: Pharmaceutical Products, comprising prescription and over-the-counter medicines across therapeutic areas including antibiotics, cardiovascular agents, gastrointestinal therapies, analgesics, respiratory treatments, and oncology drugs; Medical Devices and Consumables, providing diagnostic instruments, surgical equipment, hospital apparatus, and disposable clinical supplies; Traditional and Herbal Medicine, supplying botanical extracts, phytotherapeutic remedies, and essential oils; Dietary Supplements and Cosmetics, offering vitamins, functional nutrition products, and dermatological formulations; and Logistics and Warehousing Services, delivering Good Storage Practice and Good Distribution Practice compliant cold-chain storage, customs clearance, inventory management, and freight forwarding solutions. Founded in 1984 and headquartered in Hanoi, Vietnam, the company caters to public and private hospitals, healthcare centers, research institutes, and retail pharmacy networks across Vietnam, alongside international commercial partners spanning Asia and Europe. In recent operational developments, Vimedimex Medi-Pharma has restructured its corporate governance framework and management board, upgraded its Good Storage Practice cold-chain logistics capabilities to support temperature-sensitive biopharmaceuticals, broadened strategic commercial distribution partnerships with multinational pharmaceutical manufacturers, and accelerated the digital integration of its enterprise resource planning systems to optimize supply chain efficiency across both ethical hospital and retail channels.